Abstract
Transcription by RNA polymerase may be interrupted by pauses caused by backtracking or misincorporation that can be resolved by the conserved bacterial Gre-factors. However, the consequences of such pausing in the living cell remain obscure. Here, we developed molecular biology and transcriptome sequencing tools in the human pathogen Streptococcus pneumoniae and provide evidence that transcription elongation is rate-limiting on highly expressed genes. Our results suggest that transcription elongation may be a highly regulated step of gene expression in S. pneumoniae. Regulation is accomplished via long-living elongation pauses and their resolution by elongation factor GreA. Interestingly, mathematical modeling indicates that long-living pauses cause queuing of RNA polymerases, which results in ‘transcription traffic jams’ on the gene and thus blocks its expression. Together, our results suggest that long-living pauses and RNA polymerase queues caused by them are a major problem on highly expressed genes and are detrimental for cell viability. The major and possibly sole function of GreA in S. pneumoniae is to prevent formation of backtracked elongation complexes.
INTRODUCTION
Transcription, the first step of gene expression, is accomplished by highly conserved multisubunit RNA polymerases (RNAPs). Though initiation is the most heavily regulated step of the transcription cycle, accurate and processive elongation of RNA is essential for cell viability and homeostasis. Elongation processivity can be disrupted by pauses including backtracked pauses when the 3′ end of RNA disengages from the active center and RNAP shifts backwards (1). Backtracking is also caused by misincorporation events (2–5). Backtracked complexes can be resolved by hydrolysis of the phosphodiester bond of RNA that re-establishes the 3′ end of RNA in the active center allowing its further elongation. Based on in vitro experiments it was shown that RNA hydrolysis by the RNAP active center might contribute to overall fidelity and processivity (2–5).
Intrinsic cleavage activity of the RNAP active center can be greatly stimulated by the evolutionary conserved transcription factor Gre (some bacteria have two factors, GreA and GreB) (3,6). Gre-factor has a long coiled-coil domain, which can bind in the secondary channel toward the RNAP catalytic center. Two conserved acidic residues on the tip of this domain, D41 and E44 (Escherichia coli numbering), are thought to stabilize the second catalytic Mg2+ ion in RNAPs active center and possibly coordinate the attacking water molecule (3,6–9). Gre was shown to suppress transcription pauses and arrests (10,11), and enhance transcription fidelity in vitro (2,3). A greA deletion in E. coli also strongly affected the bistable regulation of the lac operon, which was explained by reduced transcription fidelity in vivo (12). Overexpression of E. coli GreA (GreAEco) resulted in upregulation of more than 100 genes (∼2.4% of the genome) (13). This regulation was proposed to be accomplished through stimulation of transition from transcription initiation to elongation; i.e. promoter escape. In accordance with this idea, an increase in the amount of abortive transcripts was demonstrated in the absence of GreAEco (14) and stimulation of promoter escape was suggested to be the major role of Gre in cells in general (13).
Most information on the in vivo function of Gre comes from studies using E. coli. Interpretation of the effects of Gre mutants in E. coli are hampered by the presence of two Gre-factors (GreAEco and GreBEco) and a number of factors that potentially can also bind and modulate RNAP through the secondary channel (e.g. DksA, Rnk and TraR) (15–18). The functions of these proteins are at least partially redundant. For example, the growth deficiency of a dksA mutant was complemented by multicopy greA and greB (18). Limited functional studies have been performed with bacteria besides E. coli; a chromatin immunoprecipitation study showed that Bacillus subtilis GreA is uniformly distributed over actively transcribed regions and that its inactivation resulted in the accumulation of RNAP at many promoter or promoter–proximal regions. However, no change in gene expression or phenotype was observed (19). Thus, it is clear that a full functional analysis, both in vitro and in vivo, of a nonredundant Gre-factor is missing to identify the main in vivo role of bacterial Gre -factors.
The genome of the Gram-positive human pathogen Streptococcus pneumoniae only contains a single Gre-factor, GreASpn, while no homologs of Gre or other known transcription factors that bind to RNAP's secondary channel have been identified (20,21). GreASpn contains the two conserved acidic residues present in all Gre-factors that are required for their activity (Figure 1A). A reduced genome of just 2 million base pairs together with its genetic amenability (22), makes S. pneumoniae an excellent model to study the physiological role of bacterial Gre-factors. Using transcriptome sequencing (RNA-Seq), newly developed bioinformatics tools, in vitro and in vivo analysis and mathematical modeling we show that the major in vivo function of GreASpn is to prevent long-living pauses which cause queuing or traffic jams of RNAPs and dramatically hamper gene expression.
MATERIALS AND METHODS
Strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are listed in Supplementary Table S5. The oligonucleotides used in this study are listed in Supplementary Table S6. Streptococcus pneumoniae strains were grown as standing cultures in complex C + Y medium (23) at 37°C. Detailed growth conditions are described in the supplemental information as well as the construction of the plasmids and strains used.
Protein purification
Streptococcus pneumoniae RNAP was purified by Polymin P, heparin and MonoQ chromatographies as described in (24). Streptococcus pneumoniae σA and GreA (wild-type and mutant) factors were cloned (primers rpoD start nde/rpoD sp xho r and greA start/greA end; Supplementary Table S6) and expressed using the pET expression system and purified as described in (6,25).
In vitro transcription assays
For transcription from promoters, 0.1 pmole of polymerase chain reaction (PCR) fragment carrying promoter (obtained with oligonucleotides from Supplementary Table S6) was mixed with 0.3 pmole of RNAPSpn and 0.9 pmoles of σA with or without 0.1 pmole of GreASpn in transcription buffer (TB; 33 mM Tris-Ac pH 7.9, 100 mM KGlu, 10 mM MgAc, 0.5 mM DTT, 0.1 mg/ml bovine serum albumin). All reactions were performed at 37°C. After 10 min of open complex formation, reactions were started by addition of 0.5 mM ATP, GTP and CTP and 0.15 mM [α-32P]-UTP (7.5 Ci/mmol) final for run-off transcription. For abortive initiation, assay reactions were started with 50 μM dinucleotide primer and 20 μM [α-32P]-NTP (125 Ci/mmol). For the promoter of SP_0267, UpA and UTP were used, for both ccpA and purC, ApA and GTP were used. Reactions were incubated for 10 min and stopped by addition of formamide-containing buffer. Products were resolved by denaturing (8 M urea) PAGE and revealed by Phosphorimaging (GE Healthcare).
Elongation complexes were assembled in TB lacking Mg2+ with 13 nt-long 5′ end radiolabeled RNA as described in (5), except that complexes were immobilized on streptavidin agarose beads (Fluka) through biotin of the 5′ end of the DNA template strand (3). To form misincorporated complex (mEC14), 10 mM ATP and 20 mM MgCl2 were added for 30 s. After that, 1 mM NTPs were added in the presence or absence of 10 nM GreASpn for times indicated in the figure. Reactions were stopped and products analyzed as above.
Permanganate footprinting of open complexes was performed on promoters 32P-labeled on either template or nontemplate strand, by addition of 5 mM KMnO4 for 30 s, in the presence of 0.5 mM GTP (initiating nucleotide). Reactions were terminated by addition of β-mercaptoethanol (330 mM), followed by phenol-extraction, ethanol-precipitation and 10% piperidine treatment.
In vivo measurement of transcription rate
Velocity of transcription in vivo was measured essentially as described in (26). Briefly, cells were grown in C + Y medium to OD600∼0.25, transcription of PssbB-luc-gfp was induced by adding CSP to a final concentration of 100 ng/ml. Samples were withdrawn with 10-s intervals and transcription was stopped by adding double volume of RNA Protect reagent (Qiagen). Total RNA was extracted by the hot phenol method and 5 μg was used for each dot on northern dot-blot. Early and late RNA probes were obtained by T7 RNA polymerase on PCR templates made with oligonucleotides luc early start/luc early end t7 (early probe) and gfp late start/gfp late end t7 (late probe). Dot-blotting was performed and analyzed as described in (26).
Fluorescence microscopy
Cells were grown at 37°C in plastic 5 ml capped tubes, basically as described previously (27). Microscopy pictures were taken with a Deltavision (Applied Precision) IX71Microscope (Olympus), using a CoolSNAP HQ2 camera (Princeton Instruments) and a 300 W Xenon light source through a 100x oil immersion objective (phase contrast). For more details, see the supplementary information.
RNA-Seq
Total RNA was isolated from mid exponentially growing cells and cDNA sequence libraries were prepared and sequenced as described in detail in the supplemental information. Raw sequence data are deposited and available on Sysmo-Seek (https://seek.sysmo-db.org Project Noisy Strep).
Calculating transcription mistakes using RNA-Seq data
Illumina raw sequence error rates are quite high, which might be caused by natural errors, errors introduced during cDNA library construction and Illumina-specific errors (28–30). Therefore, raw RNA-Seq data were first filtered to exclude all reads containing stretches of five or more similar nucleotides in a row (e.g. TTTTT). Furthermore, only high quality reads were selected by trimming all reads indiscriminately to 95 bp (removing the first and last 20 bases) and using the fastx toolkit to reject reads on quality (average phred score 25 and no phred scores below 15). Then the reads for both wild type and greA mutant were aligned using the Bowtie readmapper (31). The resulting mapped reads were compared with the reference genome of S. pneumoniae D39 (NCBI annotation ID NC_008533.1), read by read, position by position using a custom C++ program. All bases in the reads different from the reference were tallied and an average per read was calculated. These averages of mismatch rates were a mix between transcription errors and sequencing errors. It should be valid to compare them between wild type and mutant because sequencing errors should on average be the same given the same sequencing procedure used for both wild type and mutant samples. This approach was further validated by the fact that error rates were found to be significantly higher when cDNA libraries were prepared from the same RNA sample using lower fidelity reverse-transcriptase enzymes.
In vivo fidelity assay
Nonsense suppression was measured by determining β-galactosidase activity in cultures of pneumococcal strains carrying a multicopy plasmid containing a lacZ reporter gene with a premature stop codon early in the coding sequence. Strains were grown at 37°C in C + Y medium supplemented with 0.15 μg/ml erythromycin. At appropriate optical density (O.D. 550 = 0.3), cells were harvested, concentrated 10 times in Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCL, 1 mM MgSO4), flash frozen in liquid nitrogen and stored at −20°C. To determine β-galactosidase activity, samples were thawed at room temperature and mixed with 30 ug/ml hexadecyl trimethylammonium bromide. After 5 min of incubation at 30°C, o-nitrophenyl-β-d-galactopyranoside was added to a final concentration of 364 μg/ml. Incubation was continued at 30°C and reactions were stopped by addition of 0.23 volumes of 1 M Na2CO3. Absorbance was measured at 420 nm. Miller units of β-galactosidase activity were calculated according to the formula: (522 × A420 nm)/(time(min) × volume (ml) × O.D. 550). It should be noted that similar results were obtained by using the protein levels, as determined by a Bradford assay, instead of the O.D. of the samples at time of collection.
Simulations of the stochastic transcription model
The model of Klumpp and Hwa (32) was adjusted in the following way (also see Supporting text): Elongation complexes are described as stochastic steppers on a one-dimensional lattice. They enter the system at the promoter with the initiation attempt rate α if the promoter is free, step forward with the elongation rate ϵ and leave the system when reaching the termination site. All steps are rejected if the target site is occupied by another elongation complex. At specific (randomly selected) sites, elongation complexes may undergo transitions to a stalled state with rate f, from which they are rescued with rate 1/τ, where τ is the duration of the stall event. The effect of GreASpn is described as a strong reduction of τ (or, in alternative scenarios, as a reduction of f or an increase of ϵ). The model was simulated with the kinetic Monte Carlo approach described in (32), with a basic time step of 0.01 s. Elongation measurements were simulated by starting with an empty lattice and averaged over 1000 simulation runs. To study the dependence on expression level (modulated by varying α) and the gene length, the simulations were allowed to reach the steady state and transcription rates were obtained as time averages over 4.5 × 106 Monte Carlo steps.
RESULTS
GreASpn is crucial for cellular growth and cell morphology
To characterize the function of GreASpn in vivo we replaced greASpn with a chloramphenicol resistance cassette resulting in strain PGs6 (see supplementary methods). Besides reduced growth within agar plates (not shown), ΔgreASpn cells showed a significant increased doubling time in liquid C + Y media (43 ± 3 min for ΔgreASpn versus 28 ± 1 min for wild type, ± indicates standard deviation). Furthermore, cultures did not reach the same cell density as wild-type cells, and OD600 started to drop after prolonged incubation (Figure 1B). Microscopy analyses (not shown) revealed that the drop in OD600 was caused by cell lysis rather than by cell clumping. Note that these growth curves were started by diluting exponentially growing cells, and not directly from frozen stocks and thus do not reflect a decreased ability to survive freezing.
To exclude the possibility that the observed growth defects were due to a polar effect of the chloramphenicol resistance cassette, we introduced a copy of greASpn at the ectopic, nonessential, bgaA locus, under the control of a Zn2+ inducible promoter (PZn), resulting in strain PGs48 (ΔgreASpn, bgaA::PZn-greASpn). In the presence of 75 μM of Zn2+, normal cell growth was restored (Figure 1B). Wild-type cells grew identically in the absence or presence of added Zn2+ (data not shown). To test whether the catalytic activity of GreASpn is required for normal growth, we cloned the catalytically inactive greASpn-D43A/E46A mutant allele under the control of PZn and integrated this construct at the bgaA locus in an otherwise ΔgreASpn background (strain PGs67: ΔgreASpn, bgaA::PZn-greASpn-D43A/E46A). Strikingly, induction of GreASpn-D43A/E46A with 75 μM of Zn2+ resulted in even stronger growth defects than without zinc (Figure 1B), suggesting that the presence of inactive GreA at RNAPs catalytic site perturbs RNA polymerase functions. This observation is consistent with our earlier results, which showed that catalytically deficient GreA further ‘switches off’ intrinsic hydrolytic activity of RNAP by sequestering the Trigger Loop of the active center (3). However, although we used the minimal concentration of Zn2+ sufficient for full complementation in PGs48, we cannot formally exclude the possibility that zinc-induced GreASpn-D43A/E46A is present at higher than wild-type GreA levels. Note that for reasons currently unknown, cell lysis after prolonged incubation (>600 min) was less pronounced in strain PGs67 (ΔgreASpn, bgaA::PZn-greASpn-D43A/E46A) compared to the greA mutant (PGs6) (Figure 1B).
To examine the effects of greASpn deletion on cell morphology, strain PGs6 (ΔgreASpn) and the wild type parental strain (D39) were grown in liquid C + Y medium at 37°C and cells were harvested for microscopy at mid-exponential growth. DNA was stained with 4',6-diamidino-2-phenylindole (DAPI) and membranes were stained with the lipophilic Nile red dye. As shown in Figure 1C, ΔgreASpn cells exhibited a pleiotropic array of cell morphologies including chains of cells, small cells and large cells. In line with a defect in transcription, DAPI staining showed the occasional presence of anucleate cells in the ΔgreASpn mutant (∼2.8%, >1000 cells counted, (33)), whereas this was never the case for the wild type (Figure 1C). Complementation of ΔgreASpn with 75 μM of Zn2+ in the PGs48 strain resulted in normal cell morphology (Supplementary Figure S1). Together, these data demonstrate that the activity of GreASpn is crucial for normal growth and cell physiology in S. pneumoniae.
Absence of GreASpn slightly increases in vivo error rate in gene decoding
In vitro data suggest that Gre-factors play an important role in transcription fidelity (2,3). The above-mentioned results show that cells lacking greASpn are significantly perturbed in their physiology. This may be caused by an increased rate of transcriptional errors. To directly examine if transcription fidelity is affected by greASpn deletion in vivo, we constructed a reporter cassette that contains a constitutively expressed lacZ gene containing a stop codon mutation (P32-lacZG15stop). Functional LacZ will thus only be produced if errors in transcription or translation are regularly made. The lacZ-fidelity reporter was introduced on a replicative multicopy vector, resulting in plasmid pPGs6. The bgaA locus, encoding the only endogenous galactosidase of S. pneumoniae, was deleted in both wild type and ΔgreASpn to reduce background activity in LacZ assays. As shown in Figure 2A, a small, though significant, difference in production of functional LacZ was observed in the absence of GreASpn (<145% of wild type; P < 0.05, t-test, 8 replicates) and fidelity could be restored by GreASpn complementation (Supplementary Figure S2).
To further investigate the effects of GreASpn deletion on fidelity of transcription, we performed transcriptome sequencing (RNA-Seq). Total RNA was isolated from mid-exponentially growing cultures of wild type (D39) and ΔgreASpn (PGs6) in C + Y medium at 37°C and sequencing libraries were prepared (see Materials and Methods). To assess whether this methodology would allow us to detect transcription mistakes, we reverse transcribed total RNA with Moloney murine leukemia virus (M-MLV) reverse transcriptase (RT) and with a variant of the same enzyme called AccuScript RT which has approximately 3- to 6-fold increased fidelity according to the supplier (Agilent). The cDNA libraries were subsequently sequenced using Illumina sequencing (see Materials and Methods for details). After rigorous filtering of the reads (see Materials and Methods), we found that the cDNA libraries prepared with AccuScript RT had an overall lower mismatch rate when aligned to the reference genome sequence (GenBank Acc. NC_008533.1) compared to the cDNA libraries prepared with M-MLV (Figure 2B) thus validating this approach. If the ΔgreASpn mutant generates more mistakes during transcription than the wild type, this should be reflected in an increase of the overall mismatch rate of the RNA-Seq reads. Indeed, we found an overall mismatch rate of 0.24 and 0.55% in the ΔgreASpn mutant of cDNA libraries prepared with either AccuScript or M-MLV compared to 0.23 and 0.50% of errors in the wild type demonstrating slightly more transcription errors in the absence of GreASpn (Figure 2B). The observed mismatch rate is much higher than previously determined transcription error rates (∼10−5 per nucleotide; (34)) which are generally based on assays similar as the aforementioned lacZ assay and are thus difficult to extrapolate over the entire transcriptome. However, the error rate found here is exaggerated by mistakes introduced during reverse transcription, PCR and the process of Illumina sequencing itself (also see Supplementary Material). Because of the small differences observed by the RNA-seq analysis we cannot make any quantitative conclusions regarding the extent of reduced fidelity of the greA mutant. However, Stevens et al. showed that a 2-fold increase in decoding errors (which is much larger than observed here) causes only mild negative effects on pneumococcal cell growth (35). Taken together, we can infer that reduced transcription fidelity cannot be the major source of the observed pleiotropic effects on cell physiology of ΔgreASpn cells. Note, however, that misincorporation events lead to paused complexes formation, which may have more detrimental effects than the RNA sequence alterations (see below).
Highly expressed genes are more sensitive to lack of GreASpn
Analysis of the RNA-Seq data revealed that more than 25% of the genome was more than 2-fold differentially expressed in the ΔgreASpn mutant (Supplementary Table S1). Roughly half of these genes were more than 2-fold upregulated and about half were more than 2-fold downregulated (Supplementary Table S1). Real-time quantitative PCR on RNA isolated from wild type and ΔgreASpn cells using primers for a selected set of genes verified the RNA-Seq results (Supplementary Table S2). Among the upregulated genes were the genes belonging to the CiaR/H regulon (e.g. htrA, SPD_0775 and SPD_0913), which is activated upon envelope stress (36,37); the heat shock induced HrcA regulon (e.g. clpL and dnaK) and genes involved in DNA-repair (e.g. dprA, ssb and SPD_0715) indicating a potential conflict between replication and transcription in the absence of GreASpn (Supplementary Table S3). Also, the ccpA gene, encoding for the global catabolite repressor protein was downregulated (Supplementary Table S2). Likely because of ccpA downregulation, over one third (38 genes) of its core regulon (38) were subsequently more than 2-fold up- or downregulated (Supplementary Table S3). Perturbed expression of this global regulator alone could already account for more than 7% of all the differentially regulated genes in the ΔgreASpn mutant (Supplementary Table S3). Other noteworthy downregulated genes are involved in DNA-replication (e.g. purC, ogt and dnaX), cell wall synthesis (e.g. glmM, pbp1A and pbp1B) and protein synthesis (e.g. rpsT, efTU and prfC). Potential differences in mRNA stability in the ΔgreASpn mutant are unlikely to affect the expression patterns, as it was shown that, at any growth phase, the impact of synthesis greatly outweighs the impact of degradation on the level of all mRNAs studied (39).
Interestingly, when we plotted the fold change difference between ΔgreASpn and wild type as a function of gene expression strength (similar to a MA-plot (40)), a clear trend is visible in that highly expressed genes were affected more by the absence of GreASpn than lowly expressed genes (Figure 3A, R = 0.36). Note however that this trend did not hold for the strongly expressed ribosomal RNAs (rRNAs) (Supplementary Table S4; see Discussion). To validate this observation, we constructed a set of strains carrying synthetic constitutive promoters of different strengths driving Green Fluorescent Protein (GFP) in both the wild type and ΔgreASpn genetic backgrounds and measured total fluorescence as a proxy for transcription rate. The effect of GreASpn deletion on these promoters reaffirmed the observations at the genomic level: strongly expressed genes were more strongly affected (Figure 3B). Interestingly, we observed no correlation between gene length and GreASpn dependency (Figure 3C, R = 0.03; see below). Together, these results suggest that, in general, gene expression is reduced in the absence of GreASpn, resulting in knock-on effects that may lead to gene upregulation, such as in the case of the CcpA regulon. These global transcriptional changes may ultimately be responsible for the pleiotropic phenotypes displayed by ΔgreASpn mutant cells (Figure 1).
Transcription initiation and promoter escape are not influenced by GreASpn
We next analyzed the steps of the transcription cycle (initiation, promoter escape or elongation) affected by the absence of GreASpn. First, we tested if the absence of GreASpn influences open promoter complex formation in vitro using purified GreASpn and holo RNAPSpn. We used a PCR fragment carrying the promoter of the purC gene, which, according to the RNA-seq and qRT-PCR data, was strongly affected by GreASpn deletion (Supplementary Tables S2 and S3). Open complexes were probed with KMnO4, which modifies thymine bases only in single stranded regions of DNA. As seen from Figure 4A, the presence of GreASpn did not influence open complex formation in vitro.
Next, we analyzed abortive initiation with or without GreASpn or mutant GreASpn-D43A/E46A on several templates (ccpA, purC and SPD_0267) whose gene expression was decreased in the ΔgreASpn mutant (Supplementary Tables S2–S3). To do so, we monitored extension of a dinucleotide primer with a radiolabeled nucleoside monophosphate. The experiment demonstrated that GreASpn does not affect this stage of transcription (Figure 4B). GreA from E. coli was proposed to increase the efficiency of promoter escape (13). Therefore, we tested in vitro transcription on the same templates. As shown in Figure 4C the pattern of abortive transcripts formed during promoter escape or the ratio of abortive transcripts to the run-off RNA (product of transcription till the end of the linear template) were the same in the presence or absence of GreASpn. As expected, a number of cleavage products appeared when GreASpn was present in the reaction. We therefore conclude that GreASpn has no, or minor effects on transcription initiation and promoter escape.
GreASpn stimulates production of full-length transcripts through suppression of transcription pauses
Curiously, the amount of 100 nt run-off RNAs on the templates used in the above experiment was not increased by the presence of GreASpn (e.g. compare lanes 1 and 2 in Figure 4C). This result apparently contradicts the RNA-seq data that show increased transcription of these genes in the wild-type strain (in the presence of GreASpn). We hypothesized that GreASpn action becomes apparent only during transcription of the full-length transcripts, i.e. transcription further downstream of the +100 register. We therefore analyzed transcription in vitro on templates carrying full-length ccpA, purC and SPD_0267 DNA sequences. In agreement with our hypothesis, in the presence of GreASpn, the run-off transcripts on these templates accumulated much more readily than in its absence (Figure 5A). Earlier, we observed that RNAPSpn has lower processivity on some sequences than bacterial RNAPs from E. coli or Thermus aquaticus (41). Indeed, specific transcriptional pauses or arrests could be seen in the in vitro transcription assays in the absence of GreASpn (Figure 5A, red dots).
The in vivo analysis suggested that GreASpn does not strongly contribute to the sequence correctness of produced RNA, which apparently is achieved by the accuracy of RNAPSpn active center (42). However, misincorporation events, if not immediately resolved, lead to strong pausing of transcription (2,3,5). We tested if GreASpn can suppress misincorporation pausing by stimulating RNAPSpn to cleave the erroneous RNA. To do so, we used artificial elongation complexes that were assembled from synthetic template and nontemplate DNA oligonucleotides (fully complementary to each other) and 5′ end radiolabeled RNA oligonucleotides (see scheme in Figure 5B). Such complexes were shown to be indistinguishable from the elongation complexes obtained by transcription from a promoter (4,5,43). Assembled RNAPSpn elongation complexes were forced to misincorporate ATP at the dCMP base in the DNA template and then (without washing the complexes) allowed to elongate in the presence of all NTPs in either the presence or absence of GreASpn. Elongation in the absence of GreASpn leads to a strong pause in further extension of erroneous transcript (Figure 5B). This pause was absent in the presence of GreASpn (Figure 5B) indicating that GreASpn can also contribute to processivity of elongation by suppressing the pauses caused by misincorporation as was also shown for E. coli GreA and T. aquaticus GreA (2,5).
GreASpn does not influence the rate of elongation
So far, our results indicate that GreASpn facilitates processivity of transcription elongation by suppressing pausing by RNAPSpn. However, it is unclear whether this suppression leads to an increased rate of transcription (if GreASpn suppresses short-living pauses) or increases the chance of RNAP finishing transcription of a gene; two kinetically distinct scenarios. To distinguish between these scenarios, we examined the influence of GreASpn on the velocity of RNAPSpn elongation in vivo. To do so, we compared kinetics of synthesis of 5′- versus 3′-proximal part of an inducible genomic ∼2700 bp long luc-gfp reporter transcript in wild type and ΔgreASpn strains. The method involves isolation of total RNA at various time intervals after induction of the CSP-inducible PssbB promoter and northern blotting with probes complementary to the 5′ and 3′ ends of the luc-gfp transcript. The time elapsed between the appearances of the two signals after addition of inducer is used to estimate transcription elongation velocity (26,44). As shown in Figure 5C, the elongation kinetics were very similar for both wild type and ΔgreASpn strains (62 ± 5 versus 58 ± 5 nt/s, respectively), suggesting that GreASpn has little effect on the speed of transcribing RNAPSpn. However, in contrast to the wild type, the slope of the emerging 3′ probe signal is less steep than that of the signal emerging for the 5′ end probe. This cannot be explained by altered Rho-dependent polarity, since S. pneumoniae does not have a Rho factor (20,21). Therefore, this result indicates that not all of the RNAPs that started transcription from the promoter were able to reach the terminator in the ΔgreASpn strain within the time of the experiment. Thus, we conclude that GreASpn suppresses the long-living or dead-end pauses, which otherwise preclude RNAPSpn from finishing transcription.
Development and characterization of a stochastic model of GreASpn-dependent transcription
The above results suggest that GreASpn augments transcription by restarting stalled elongation complexes. However, this does not intuitively explain why highly expressed genes are particularly sensitive to the lack of GreASpn while longer genes are not (Figure 3). To strengthen this conclusion and to gain more insights in the molecular mechanism involved, we developed a stochastic model of transcription in the presence and absence of GreASpn. We built a model upon a framework previously established to model the effects of pausing, termination and antitermination on rRNA transcription in E. coli (32). The model takes into account that GreASpn does not affect initiation and promoter escape. We used the model to test three scenarios, where stimulation of transcript elongation by GreASpn is due to either an increase of the stepping rate (the elongation rate without pauses), a reduction of the duration of the pauses or of the frequency of pauses (Figure 6, Supplementary Figure S3). Simulations of all three scenarios were consistent with the experimental observations that: highly expressed genes are more sensitive to the lack of GreASpn (Figure 6A, Supplementary Figure S3A and D); and that absence of GreASpn does not significantly impact the expression of longer genes (Figure 6B. Supplementary Figure S3B and E). However, only the simulations where GreASpn was taken to affect pausing could recover the observed pattern of the elongation experiment and show that less RNAPs reach the end of the gene in the absence of GreASpn as indicated by the lower slope in the accumulation of the 3′ probe’ (Figure 6C, Supplementary Figure S3C and F). The simulations cannot definitely distinguish whether GreASpn reduced the duration or the frequency of pauses, although the agreement with the elongation experiments is slightly better for the pause-duration scenario. Based on the known mechanism of Gre-factors in E. coli (2,5,10), we consider a reduction of the pause duration as more likely. Moreover, simulations of the scenario of a reduced pause frequency requires very rare, but very long pauses in the wild type, for which we have no evidence. Thus, the simulations provide additional support for our interpretation of the data in Figures 4 and 5. Importantly, simulations explain the reduced transcription in the absence of GreASpn by the formation of transcription ‘traffic jams.’ These traffic jams are formed by RNAPs that queue behind the paused elongation complex (Figure 6D). The model also predicts that averaged velocity of transcription elongation (i.e. including pauses and traffic jams) is the main rate-limiting factor for highly expressed genes (Supplementary Figure S4).
DISCUSSION
Bacterial Gre-factors have been mostly studied in E. coli and it has become clear that, at least in vitro, Gre-factors stimulate RNAPs intrinsic proofreading activity and in that way speed up transcription and seem to be involved in nearly all steps of transcription: initiation, elongation and fidelity. The consequences of the lack of Gre-factor for the cell's physiology in vivo, however, have remained largely elusive. This can be partly explained because of the genetic redundancy present: E. coli contains two Gre-factors, GreA and GreB and several additional regulators, DksA, Rnk and TraR, which can also bind to the secondary channel of RNAP (15–17). Thus, interpretation of the physiological function of Gre has turned out to be difficult (18). Here, we studied the in vivo role of the Gre-factor of S. pneumoniae, an organism that only contains one Gre-factor, GreASpn and no other homologs. Furthermore, the S. pneumoniae genome does not code for any other secondary channel binding homologs of Gre. The importance of a functional Gre-factor became immediately clear by analyzing cells of the greASpn knockout mutant, which are severely perturbed in their growth (Figure 1). Importantly, we were not able to pick up fast growing suppressors by plate or liquid growth assays (data not shown), indicating that single mutations in RNAP or elsewhere in the genome cannot compensate for the loss of function of GreASpn. Together with RNA-Seq and biochemical assays we obtained a clear picture of the in vitro and in vivo characteristics of GreASpn and the ramifications for cells to live without GreASpn (Figures 2–5). These data allowed us to formulate a stochastic mathematical model of transcription, which predicts that in the absence of GreASpn, RNAP queues rapidly arise and that these traffic jams compromise gene expression (Figure 6). Interestingly, the model could also reproduce the observation that highly expressed genes were downregulated relatively more than lowly expressed genes (Figure 3). A likely explanation for this phenomenon is that highly expressed genes initiate transcription very frequently and thus the total transcription rate is rather limited by the elongation rate (Supplementary Figure S4), while lowly expressed genes fire transcription infrequently and their total transcription rates are thus limited by transcription initiation; which we show is not affected in the absence of GreASpn (Figure 4).
RNAPs and ribosomes were proposed to cooperate to rescue backtracked RNAPs by ‘pushing’ them forward (26,45). This model however would predict that in the presence of excessive backtracking the highly expressed genes must be affected less by the absence of GreA than low-expressed genes, because the trailing RNAPs and ribosomes would ‘push’ paused RNAP from backtracking. Our data show the contrary pattern of transcription, suggesting that the cooperation of RNAPs and ribosomes to rescue backtracked complexes may not be efficient enough to suppress deletion of GreASpn. Instead our results suggest that the paused RNAP rather causes queuing of the trailing RNAPs. The situation might be different for rRNAs that are not translated and are not reduced in the greASpn mutant, whereas genes encoding ribosomal proteins are downregulated (Supplementary Table S4). The rate of transcription elongation on rRNAs is roughly 2-fold higher than that of protein coding genes (46,47). Fast transcription suggests smaller amount of pausing sites thus decreasing the chances of backtracking. In addition, extensive secondary structures forming in the nascent rRNAs would physically block extensive backtracking. These properties may alleviate the necessity of GreASpn. Whether this hypothesis is correct requires further investigation.
Backtracked transcription elongation complexes, which can be resolved by Gre-factors, were proposed to cause DNA-damage by collisions with the DNA-replication machinery (48,49). The collisions may also be suppressed by point mutations in RNAP that were proposed to destabilize elongation complexes and/or reduce backtracking (48). The absence of slow-growth suppressors in the greASpn knockout mutant however, suggests that S. pneumoniae RNAP cannot easily overcome backtracking possibly because it is poorly processive (e.g. compared to E. coli RNAP; (41)). Our data also suggest that queues of RNAPs, rather than single backtracked RNAP, may be a major problem for replication fork progression.
Transcription initiation is generally assumed to be rate limiting and the most regulated step of gene expression. Here, we present evidence that elongation of transcription can also determine the rate of gene expression and, thus, represent a major point for gene regulation in S. pneumoniae and possibly in other bacteria. Indeed, many transcription elongation factors such as λN and λQ (of bacteriophage λ), NusA and NusG (of E. coli) that affect transcription elongation have been shown to affect gene expression (50). Interestingly, it was recently shown that the transcription rate of eukaryotic RNAPII (Pol II) varies on genes demonstrating that elongation is also a regulated rate-limiting step during transcription in higher organisms (51).
Together, we now propose the following model for the major role of bacterial Gre-cleavage factors in vivo (Figure 7). After initiation of transcription and promoter escape, RNAP pauses on intrinsic signals (52) or as a result of misincorporation. These stalls, if not resolved, might lead to backtracking and cause queues of RNAP and, as a result, transcription ‘traffic jams’ arise (Figure 7). Importantly, these queues or traffic jams of RNAPs dramatically hamper gene expression and are detrimental for the cell. Future experiments, for instance chromatin immunoprecipitation assays using RNAPSpn antibodies and nascent transcript sequencing could be performed to test our model. Since our model predicts stochastic backtracking by RNAPs, single molecule and single-cell experiments might be more informative than bulk assays, and this is something we are currently pursuing. Indeed, nascent RNA-sequencing experiments showed no differences in RNAPEco pausing in the absence of Gre indicating that backtracked pauses may occur randomly (52).
While S. pneumoniae provides a useful (minimal) model organism to study the bacterial transcription cycle in vivo, S. pneumoniae is also a serious human pathogen annually killing nearly 1 million children (53). Furthermore, over the last decades, S. pneumoniae resistance to existing antibiotics has spread and is now a serious problem (54). Our results reveal Gre-factor as a possible target for innovative drug design. Furthermore, our unique methodology, combining experimental methods on both the molecular (biochemical) level and the systems level and mathematical modeling, may serve as an example for studies on unrelated systems.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Acknowledgments
We thank Harma Karsens for the construction of the P32-gfp constructs and Jean-Pierre Claverys for the luc gene. We thank Anne de Jong and Fritz Thuemmler for help with RNA-Seq data analysis.
Footnotes
The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.
FUNDING
Sysmo2 Grant (Noisy Strep) [to J.W.V., N.Z.]; European Research Council [337399-PneumoCell to J.W.V., ERC-2007-StG 202994-MTP to N.Z.]; Netherlands Organisation for Scientific Research (NWO-ALW VIDI) [864.12.001 to J.W.V.]; UK Biotechnology and Biological Sciences Research Council [to N.Z]. Funding for open access charge: NWO.
Conflict of interest statement. None declared.
REFERENCES
- 1.Komissarova N., Kashlev M. Transcriptional arrest: Escherichia coli RNA polymerase translocates backward, leaving the 3’ end of the RNA intact and extruded. Proc. Natl. Acad. Sci. U.S.A. 1997;94:1755–1760. doi: 10.1073/pnas.94.5.1755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Erie D.A., Hajiseyedjavadi O., Young M.C., von Hippel P.H. Multiple RNA polymerase conformations and GreA: control of the fidelity of transcription. Science. 1993;262:867–873. doi: 10.1126/science.8235608. [DOI] [PubMed] [Google Scholar]
- 3.Roghanian M., Yuzenkova Y., Zenkin N. Controlled interplay between trigger loop and Gre factor in the RNA polymerase active centre. Nucleic Acids Res. 2011;39:4352–4359. doi: 10.1093/nar/gkq1359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Yuzenkova Y., Zenkin N. Central role of the RNA polymerase trigger loop in intrinsic RNA hydrolysis. Proc. Natl. Acad. Sci. U.S.A. 2010;107:10878–10883. doi: 10.1073/pnas.0914424107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Zenkin N., Yuzenkova Y., Severinov K. Transcript-assisted transcriptional proofreading. Science. 2006;313:518–520. doi: 10.1126/science.1127422. [DOI] [PubMed] [Google Scholar]
- 6.Laptenko O., Lee J., Lomakin I., Borukhov S. Transcript cleavage factors GreA and GreB act as transient catalytic components of RNA polymerase. EMBO J. 2003;22:6322–6334. doi: 10.1093/emboj/cdg610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Opalka N., Chlenov M., Chacon P., Rice W.J., Wriggers W., Darst S.A. Structure and function of the transcription elongation factor GreB bound to bacterial RNA polymerase. Cell. 2003;114:335–345. doi: 10.1016/s0092-8674(03)00600-7. [DOI] [PubMed] [Google Scholar]
- 8.Sosunova E., Sosunov V., Kozlov M., Nikiforov V., Goldfarb A., Mustaev A. Donation of catalytic residues to RNA polymerase active center by transcription factor Gre. Proc. Natl. Acad. Sci. U.S.A. 2003;100:15469–15474. doi: 10.1073/pnas.2536698100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tagami S., Sekine S.-I., Kumarevel T., Hino N., Murayama Y., Kamegamori S., Yamamoto M., Sakamoto K., Yokoyama S. Crystal structure of bacterial RNA polymerase bound with a transcription inhibitor protein. Nature. 2010;468:978–982. doi: 10.1038/nature09573. [DOI] [PubMed] [Google Scholar]
- 10.Borukhov S., Sagitov V., Goldfarb A. Transcript cleavage factors from E. coli. Cell. 1993;72:459–466. doi: 10.1016/0092-8674(93)90121-6. [DOI] [PubMed] [Google Scholar]
- 11.Toulmé F., Mosrin-Huaman C., Sparkowski J., Das A., Leng M., Rahmouni A.R. GreA and GreB proteins revive backtracked RNA polymerase in vivo by promoting transcript trimming. EMBO J. 2000;19:6853–6859. doi: 10.1093/emboj/19.24.6853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gordon A.J., Halliday J.A., Blankschien M.D., Burns P.A., Yatagai F., Herman C. Transcriptional infidelity promotes heritable phenotypic change in a bistable gene network. PLoS.Biol. 2009;7:e44. doi: 10.1371/journal.pbio.1000044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Stepanova E., Lee J., Ozerova M., Semenova E., Datsenko K., Wanner B.L., Severinov K., Borukhov S. Analysis of promoter targets for Escherichia coli transcription elongation factor GreA in vivo and in vitro. J. Bacteriol. 2007;189:8772–8785. doi: 10.1128/JB.00911-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Goldman S.R., Ebright R.H., Nickels B.E. Direct detection of abortive RNA transcripts in vivo. Science. 2009;324:927–928. doi: 10.1126/science.1169237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Blankschien M.D., Potrykus K., Grace E., Choudhary A., Vinella D., Cashel M., Herman C. TraR, a homolog of a RNAP secondary channel interactor, modulates transcription. PLoS Genet. 2009;5:e1000345. doi: 10.1371/journal.pgen.1000345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lamour V., Rutherford S.T., Kuznedelov K., Ramagopal U.A., Gourse R.L., Severinov K., Darst S.A. Crystal structure of Escherichia coli Rnk, a new RNA polymerase-interacting protein. J. Mol. Biol. 2008;383:367–379. doi: 10.1016/j.jmb.2008.08.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Rutherford S.T., Lemke J.J., Vrentas C.E., Gaal T., Ross W., Gourse R.L. Effects of DksA, GreA, and GreB on transcription initiation: insights into the mechanisms of factors that bind in the secondary channel of RNA polymerase. J. Mol. Biol. 2007;366:1243–1257. doi: 10.1016/j.jmb.2006.12.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Vinella D., Potrykus K., Murphy H., Cashel M. Effects on growth by changes of the balance between GreA, GreB, and DksA suggest mutual competition and functional redundancy in Escherichia coli. J. Bacteriol. 2012;194:261–273. doi: 10.1128/JB.06238-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kusuya Y., Kurokawa K., Ishikawa S., Ogasawara N., Oshima T. Transcription factor GreA contributes to resolving promoter-proximal pausing of RNA polymerase in Bacillus subtilis cells. J. Bacteriol. 2011;193:3090–3099. doi: 10.1128/JB.00086-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hoskins J., Alborn W.E., Arnold J., Blaszczak L.C., Burgett S., DeHoff B.S., Estrem S.T., Fritz L., Fu D.J., Fuller W., et al. Genome of the bacterium Streptococcus pneumoniae strain R6. J. Bacteriol. 2001;183:5709–5717. doi: 10.1128/JB.183.19.5709-5717.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lanie J.A., Ng W.L., Kazmierczak K.M., Andrzejewski T.M., Davidsen T.M., Wayne K.J., Tettelin H., Glass J.I., Winkler M.E. Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J. Bacteriol. 2007;189:38–51. doi: 10.1128/JB.01148-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Claverys J.P., Martin B., Polard P. The genetic transformation machinery: composition, localization, and mechanism. FEMS Microbiol. Rev. 2009;33:643–656. doi: 10.1111/j.1574-6976.2009.00164.x. [DOI] [PubMed] [Google Scholar]
- 23.Martin B., Garcia P., Castanie M.P., Claverys J.P. The recA gene of Streptococcus pneumoniae is part of a competence-induced operon and controls lysogenic induction. Mol. Microbiol. 1995;15:367–379. doi: 10.1111/j.1365-2958.1995.tb02250.x. [DOI] [PubMed] [Google Scholar]
- 24.Kashlev M., Nudler E., Severinov K., Borukhov S., Komissarova N., Goldfarb A. Histidine-tagged RNA polymerase of Escherichia coli and transcription in solid phase. Meth. Enzymol. 1996;274:326–334. doi: 10.1016/s0076-6879(96)74028-4. [DOI] [PubMed] [Google Scholar]
- 25.Zenkin N., Kulbachinskiy A., Yuzenkova Y., Mustaev A., Bass I., Severinov K., Brodolin K. Region 1.2 of the RNA polymerase sigma subunit controls recognition of the -10 promoter element. EMBO J. 2007;26:955–964. doi: 10.1038/sj.emboj.7601555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Proshkin S., Rahmouni A.R., Mironov A., Nudler E. Cooperation between translating ribosomes and RNA polymerase in transcription elongation. Science. 2010;328:504–508. doi: 10.1126/science.1184939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.de Jong I., Beilharz K., Kuipers O.P., Veening J.W. Live Cell Imaging of Bacillus subtilis and Streptococcus pneumoniae using Automated Time-lapse Microscopy. J. Vis. Exp. 2011;3145 doi: 10.3791/3145. doi:10.3791/3145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Meacham F., Boffelli D., Dhahbi J., Martin D.I., Singer M., Pachter L. Identification and correction of systematic error in high-throughput sequence data. BMC Bioinformatics. 2011;12:1–11. doi: 10.1186/1471-2105-12-451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Minoche A.E., Dohm J.C., Himmelbauer H. Evaluation of genomic high-throughput sequencing data generated on Illumina HiSeq and Genome Analyzer systems. Genome Biol. 2011;12:R112. doi: 10.1186/gb-2011-12-11-r112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Nakamura K., Oshima T., Morimoto T., Ikeda S., Yoshikawa H., Shiwa Y., Ishikawa S., Linak M.C., Hirai A., Takahashi H. Sequence-specific error profile of Illumina sequencers. Nucleic Acids Res. 2011;30:e90. doi: 10.1093/nar/gkr344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10:R25. doi: 10.1186/gb-2009-10-3-r25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Klumpp S., Hwa T. Stochasticity and traffic jams in the transcription of ribosomal RNA: intriguing role of termination and antitermination. Proc. Natl. Acad. Sci. U.S.A. 2008;105:18159–18164. doi: 10.1073/pnas.0806084105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kjos M., Veening J.-W. Tracking of chromosome dynamics in live Streptococcus pneumoniae reveals that transcription promotes chromosome segregation. Mol. Microbiol. 2014;91:1088–1105. doi: 10.1111/mmi.12517. [DOI] [PubMed] [Google Scholar]
- 34.Ninio J. Connections between translation, transcription and replication error-rates. Biochimie. 1991;73:1517–1523. doi: 10.1016/0300-9084(91)90186-5. [DOI] [PubMed] [Google Scholar]
- 35.Stevens K.E., Chang D., Zwack E.E., Sebert M.E. Competence in Streptococcus pneumoniae is regulated by the rate of ribosomal decoding errors. MBio. 2011;2 doi: 10.1128/mBio.00071-11. e00071-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Halfmann A., Kovacs M., Hakenbeck R., Bruckner R. Identification of the genes directly controlled by the response regulator CiaR in Streptococcus pneumoniae: five out of 15 promoters drive expression of small non-coding RNAs. Mol. Microbiol. 2007;66:110–126. doi: 10.1111/j.1365-2958.2007.05900.x. [DOI] [PubMed] [Google Scholar]
- 37.Zahner D., Kaminski K., van der Linden M., Mascher T., Meral M., Hakenbeck R. The ciaR/ciaH regulatory network of Streptococcus pneumoniae. J. Mol. Microbiol. Biotechnol. 2002;4:211–216. [PubMed] [Google Scholar]
- 38.van Opijnen T., Bodi K.L., Camilli A. Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat. Methods. 2009;6:767–772. doi: 10.1038/nmeth.1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Dressaire C., Picard F., Redon E., Loubière P., Queinnec I., Girbal L., Cocaign-Bousquet M. Role of mRNA stability during bacterial adaptation. PLoS ONE. 2013;8:e59059. doi: 10.1371/journal.pone.0059059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Dudoit S., Yang Y.H., Callow M.J., Speed T.P. Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Stat. Sin. 2002;12:111–140. [Google Scholar]
- 41.Bochkareva A., Yuzenkova Y., Tadigotla V.R., Zenkin N. Factor-independent transcription pausing caused by recognition of the RNA-DNA hybrid sequence. EMBO J. 2012;31:630–639. doi: 10.1038/emboj.2011.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Yuzenkova Y., Bochkareva A., Tadigotla V.R., Roghanian M., Zorov S., Severinov K., Zenkin N. Stepwise mechanism for transcription fidelity. BMC Biol. 2010;8:1–15. doi: 10.1186/1741-7007-8-54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sidorenkov I., Komissarova N., Kashlev M. Crucial role of the RNA:DNA hybrid in the processivity of transcription. Mol. Cell. 1998;2:55–64. doi: 10.1016/s1097-2765(00)80113-6. [DOI] [PubMed] [Google Scholar]
- 44.Vogel U., Sørensen M., Pedersen S., Jensen K.F., Kilstrup M. Decreasing transcription elongation rate in Escherichia coli exposed to amino acid starvation. Mol. Microbiol. 1992;6:2191–2200. doi: 10.1111/j.1365-2958.1992.tb01393.x. [DOI] [PubMed] [Google Scholar]
- 45.Epshtein V., Nudler E. Cooperation between RNA polymerase molecules in transcription elongation. Science. 2003;300:801–805. doi: 10.1126/science.1083219. [DOI] [PubMed] [Google Scholar]
- 46.Vogel U., Jensen K.F. Effects of the antiterminator BoxA on transcription elongation kinetics and ppGpp inhibition of transcription elongation in Escherichia coli. J. Biol. Chem. 1995;270:18335–18340. doi: 10.1074/jbc.270.31.18335. [DOI] [PubMed] [Google Scholar]
- 47.Klumpp S., Hwa T. Traffic patrol in the transcription of ribosomal RNA. RNA Biol. 2009;6:392–394. doi: 10.4161/rna.6.4.8952. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Dutta D., Shatalin K., Epshtein V., Gottesman M.E., Nudler E. Linking RNA polymerase backtracking to genome instability in E. coli. Cell. 2011;146:533–543. doi: 10.1016/j.cell.2011.07.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Tehranchi A.K., Blankschien M.D., Zhang Y., Halliday J.A., Srivatsan A., Peng J., Herman C., Wang J.D. The transcription factor DksA prevents conflicts between DNA replication and transcription machinery. Cell. 2010;141:595–605. doi: 10.1016/j.cell.2010.03.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Roberts J.W., Shankar S., Filter J.J. RNA polymerase elongation factors. Annu. Rev. Microbiol. 2008;62:211–233. doi: 10.1146/annurev.micro.61.080706.093422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Danko C.G., Hah N., Luo X., Martins A.L., Core L., Lis J.T., Siepel A., Kraus W.L. Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol. Cell. 2013;50:212–222. doi: 10.1016/j.molcel.2013.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Larson M.H., Mooney R.A., Peters J.M., Windgassen T., Nayak D., Gross C.A., Block S.M., Greenleaf W.J., Landick R., Weissman J.S. A pause sequence enriched at translation start sites drives transcription dynamics in vivo. Science. 2014;344:1042–1047. doi: 10.1126/science.1251871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., Lee E., Mulholland K., Levine O.S., Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902. doi: 10.1016/S0140-6736(09)61204-6. [DOI] [PubMed] [Google Scholar]
- 54.van der Poll T., Opal S.M. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374:1543–1556. doi: 10.1016/S0140-6736(09)61114-4. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.